Welcome to our dedicated page for Embotelladora Andina S.A. Series B news (Ticker: AKO.B), a resource for investors and traders seeking the latest updates and insights on Embotelladora Andina S.A. Series B stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Embotelladora Andina S.A. Series B's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Embotelladora Andina S.A. Series B's position in the market.
Coca-Cola Andina has filed its Annual Report on Form 20-F for the fiscal year ending December 31, 2022, with the U.S. Securities and Exchange Commission. This report is available on the company’s website at www.koandina.com and the SEC’s site at www.sec.gov. The report includes the company's audited financial statements for the fiscal year. Shareholders can request a hard copy of this report free of charge through the contact information provided. For further inquiries, investors can reach out to Paula Vicuña, the Investor Relations Officer, in Santiago, Chile.
FAQ
What is the current stock price of Embotelladora Andina S.A. Series B (AKO.B)?
What is the market cap of Embotelladora Andina S.A. Series B (AKO.B)?
